MS Pharma Inc. – FDA Inspection, Mar 15, 2019

Record Details

This FDA Inspection record concerns MS Pharma Inc., with an inspection on March 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: MS Pharma Inc.
Inspection Date: March 15, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Jeffrey P. Raimondi (Investigator)

View Company Profile

ID · bd0d37b1-3d31-4a50-adaf-5b45c6090b15

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1082763
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

FDA Citations

21 CFR 211.22(a)Authority lacking to review records, investigate errors

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MS Pharma Inc.

FDA Inspection

MS Pharma Inc.March 15, 2019